Published in J Am Soc Nephrol on April 06, 2005
Hemoglobin and plasma vitamin C levels in patients on peritoneal dialysis. Perit Dial Int (2010) 0.99
Iron and anemia in human biology: a review of mechanisms. Heart Fail Rev (2008) 0.96
Low levels of vitamin C in dialysis patients is associated with decreased prealbumin and increased C-reactive protein. BMC Nephrol (2011) 0.93
Iron therapy for renal anemia: how much needed, how much harmful? Pediatr Nephrol (2007) 0.93
Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial. J Am Soc Nephrol (2013) 0.93
End-stage renal disease in Taiwan: a case-control study. J Epidemiol (2009) 0.92
GST M1 polymorphism associates with DNA oxidative damage and mortality among hemodialysis patients. J Am Soc Nephrol (2008) 0.89
The effect of vitamin C on parathyroid hormone in patients on hemodialysis with secondary hyperparathyroidism: a double blind, placebo-controlled study. Nephrourol Mon (2013) 0.85
Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review. Semin Dial (2013) 0.80
Effect of Vitamin C Supplementation on C-reactive Protein Levels in Patients Undergoing Hemodialysis: A Randomized, Double Blind, Placebo-Controlled Study. Nephrourol Mon (2013) 0.79
Lifestyle Behaviours and Plasma Vitamin C and β-Carotene Levels from the ELAN Population (Liège, Belgium). J Nutr Metab (2011) 0.78
Systemic Redox Imbalance in Chronic Kidney Disease: A Systematic Review. Oxid Med Cell Longev (2016) 0.76
Beyond Framingham: cardiovascular risk profiling in ESRD. J Am Soc Nephrol (2005) 0.76
Vitamins (A, C and E) and oxidative status of hemodialysis patients treated with HFR and HFR-Supra. BMC Nephrol (2016) 0.75
Association of GSTO1 and GSTO2 Polymorphism with Risk of End-Stage Renal Disease Development and Patient Survival. J Med Biochem (2016) 0.75
Effect of vitamin C on endothelial function of children with chronic renal failure: An experimental study. Adv Biomed Res (2015) 0.75
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. Int J Mol Sci (2017) 0.75
Protective Role for Antioxidants in Acute Kidney Disease. Nutrients (2017) 0.75
Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med (2010) 5.50
The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity (2008) 4.44
Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant (2004) 4.27
Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol (2002) 3.34
Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol (2002) 2.88
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights. Kidney Int (2012) 2.38
Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML. Am J Hematol (2011) 2.29
The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med (2004) 2.27
Gender differences in outcome of conservatively treated patients with asymptomatic high grade carotid stenosis. Stroke (2005) 2.10
Perioperative beta-blockers for preventing surgery-related mortality and morbidity. Cochrane Database Syst Rev (2014) 2.08
Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol (2002) 2.02
Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab (2004) 1.92
Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv (2009) 1.90
Hypotension and bradycardia after elective carotid stenting: frequency and risk factors. J Endovasc Ther (2003) 1.85
Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant (2002) 1.81
D-dimer in ruling out acute aortic dissection: a systematic review and prospective cohort study. Eur Heart J (2007) 1.79
Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. Clin J Am Soc Nephrol (2011) 1.74
Renal artery PTA and stent implantation: immediate and late clinical and morphological outcome. Wien Klin Wochenschr (2002) 1.69
Dental and periodontal status and risk for progression of carotid atherosclerosis: the inflammation and carotid artery risk for atherosclerosis study dental substudy. Stroke (2006) 1.65
Perioperative beta-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. Anesth Analg (2007) 1.65
Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study. BMJ (2009) 1.61
Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here? Nephrol Dial Transplant (2004) 1.59
Statin use is associated with prolonged survival of renal transplant recipients. J Am Soc Nephrol (2008) 1.54
Angiotensin converting enzyme DD genotype is associated with hypertensive crisis. Crit Care Med (2002) 1.53
Non-conventional markers of atherosclerosis before and after gastric banding surgery. Eur Heart J (2009) 1.53
Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest (2005) 1.52
Long-term patient and graft survival in the eurotransplant senior program: a single-center experience. Transplantation (2005) 1.51
Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis. Urology (2002) 1.51
Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients. Transpl Int (2012) 1.50
Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis (2002) 1.46
Is there improvement of "vascular depression" after carotid artery stent placement? Radiology (2006) 1.44
Early basal insulin therapy decreases new-onset diabetes after renal transplantation. J Am Soc Nephrol (2012) 1.44
Influence of plasma immunoglobulin level on antibody synthesis. Blood (2002) 1.44
Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patients. Clin Biochem (2012) 1.44
A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation. J Immunol (2010) 1.42
Long-segment SFA stenting--the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther (2005) 1.42
The effect of ACE inhibitor and angiotensin II blocker therapy on early posttransplant kidney graft function. Am J Kidney Dis (2004) 1.42
Insulin, C-peptide, and restenosis after femoral artery balloon angioplasty in type II diabetic and nondiabetic patients. J Vasc Interv Radiol (2005) 1.42
Plaque echolucency is not associated with the risk of stroke in carotid stenting. Stroke (2006) 1.42
De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates--randomized controlled trial. Radiology (2008) 1.41
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study. Wien Klin Wochenschr (2002) 1.39
Serum amyloid A in uremic HDL promotes inflammation. J Am Soc Nephrol (2012) 1.27
Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Nephrol Dial Transplant (2011) 1.27
Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study. Clin Nephrol (2012) 1.26
Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2011) 1.25
The versatility of HDL: a crucial anti-inflammatory regulator. Eur J Clin Invest (2010) 1.21
Reduction of adverse citrate reactions during autologous large-volume PBPC apheresis by continuous infusion of calcium-gluconate. Transfusion (2003) 1.20
Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease. Arterioscler Thromb Vasc Biol (2006) 1.18
PRE-dialysis survey on anaemia management. Nephrol Dial Transplant (2003) 1.16
Significance of interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol (2013) 1.14
Effect of early correction of anemia on the progression of CKD. Am J Kidney Dis (2006) 1.12
Disruption of the interaction of T cells with antigen-presenting cells by the active leflunomide metabolite teriflunomide: involvement of impaired integrin activation and immunologic synapse formation. Arthritis Rheum (2005) 1.12
Pure red cell aplasia induced by erythropoiesis-stimulating agents. Clin J Am Soc Nephrol (2008) 1.11
A "defined baseline" in PTH monitoring increases surgical success in patients with multiple gland disease. Surgery (2007) 1.08
Urinary tract infections after renal transplantation. Curr Opin Urol (2002) 1.07
Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther (2005) 1.06
High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. Kidney Int (2003) 1.06
Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells. Blood (2011) 1.06
Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant (2002) 1.05
Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res (2002) 1.05
Low serum magnesium predicts neurological events in patients with advanced atherosclerosis. Stroke (2003) 1.04
Quick PTH assay cannot predict incomplete parathyroidectomy in patients with renal hyperparathyroidism. Surgery (2005) 1.04
Immune dysfunction in uremia—an update. Toxins (Basel) (2012) 1.03
Prognostic impact of fibrinogen in carotid atherosclerosis: nonspecific indicator of inflammation or independent predictor of disease progression? Stroke (2005) 1.03
Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure. Eur J Clin Invest (2011) 1.02
Patient and graft survival in older kidney transplant recipients: does age matter? J Am Soc Nephrol (2004) 1.02
Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol (2002) 1.02
First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg (2011) 1.01
HSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney disease. Clin Chim Acta (2011) 1.01
C-reactive protein predicts future cardiovascular events in patients with carotid stenosis. Stroke (2007) 1.00
Glucose metabolism after renal transplantation. Diabetes Care (2013) 0.99
Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. Diabetes (2002) 0.99
Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age). Eur J Clin Invest (2011) 0.99
Bacterial metabolite interference with maturation of human monocyte-derived dendritic cells. J Leukoc Biol (2002) 0.99
Treatment of subclavian-axillary vein thrombosis: long-term outcome of anticoagulation versus systemic thrombolysis. Thromb Res (2002) 0.98
Colon-specific regulation of vitamin D hydroxylases--a possible approach for tumor prevention. Carcinogenesis (2005) 0.98
Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care (2009) 0.98
Impairment of transendothelial leukocyte migration by iron complexes. J Am Soc Nephrol (2003) 0.98
Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Stroke (2011) 0.98
Effect of dialysis on serum/plasma levels of free immunoglobulin light chains in end-stage renal disease patients. Nephrol Dial Transplant (2002) 0.98
Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol Dial Transplant (2013) 0.97
Sexual hormone abnormalities in male patients with renal failure. Nephrol Dial Transplant (2002) 0.97
Sodium setpoint and sodium gradient: influence on plasma sodium change and weight gain. Am J Nephrol (2010) 0.97
Quantification of internal carotid artery stenosis with duplex US: comparative analysis of different flow velocity criteria. Radiology (2004) 0.96
Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis. Eur Heart J (2005) 0.96
Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. J Vasc Surg (2005) 0.96
Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity. Transpl Int (2010) 0.96
PTH spikes during parathyroid exploration--a possible pitfall during PTH monitoring? Langenbecks Arch Surg (2006) 0.96
Effects of smoking cessation on β-cell function, insulin sensitivity, body weight, and appetite. Eur J Endocrinol (2014) 0.95
Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology (2004) 0.94
The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebrovascular events: the influence of other vascular risk factors. Thromb Res (2004) 0.94
Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Stroke (2010) 0.93
Impact of alphaENaC polymorphisms on the risk of ischemic cerebrovascular events: a multicenter case-control study. Clin Chem (2005) 0.93
Determinants of the complement-fixing ability of recipient presensitization against HLA antigens. Transplantation (2007) 0.93